Swiss National Bank
HRMY icon

Swiss National Bank’s Harmony Biosciences HRMY Stock Holding History

Swiss National Bank’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.48M Buy
95,700
+10,600
+12% +$334K ﹤0.01% 1646
2026
Q1 		$2.38M Hold
85,100
– – ﹤0.01% 1761
2025
Q4 		$3.18M Buy
85,100
+1,600
+2% +$52.6K ﹤0.01% 1619
2025
Q3 		$2.3M Buy
83,500
+1,300
+2% +$44.8K ﹤0.01% 1789
2025
Q2 		$2.6M Sell
82,200
-700
-0.8% -$22.5K ﹤0.01% 1640
2025
Q1 		$2.75M Buy
82,900
+4,700
+6% +$168K ﹤0.01% 1583
2024
Q4 		$2.69M Buy
78,200
+17,200
+28% +$591K ﹤0.01% 1686
2024
Q3 		$2.44M Sell
61,000
-500
-0.8% -$17.6K ﹤0.01% 1745
2024
Q2 		$1.86M Sell
61,500
-2,100
-3% -$63.1K ﹤0.01% 1855
2024
Q1 		$2.14M Sell
63,600
-1,500
-2% -$48.1K ﹤0.01% 1802
2023
Q4 		$2.1M Sell
65,100
-14,000
-18% -$391K ﹤0.01% 1798
2023
Q3 		$2.59M Buy
79,100
+7,300
+10% +$253K ﹤0.01% 1678
2023
Q2 		$2.53M Buy
71,800
+20,600
+40% +$711K ﹤0.01% 1739
2023
Q1 		$1.67M Sell
51,200
-5,900
-10% -$269K ﹤0.01% 1949
2022
Q4 		$3.15M Buy
57,100
+1,100
+2% +$60.5K ﹤0.01% 1603
2022
Q3 		$2.48M Buy
56,000
+900
+2% +$43.9K ﹤0.01% 1722
2022
Q2 		$2.69M Buy
55,100
+13,600
+33% +$612K ﹤0.01% 1711
2022
Q1 		$2.02M Buy
41,500
+3,900
+10% +$159K ﹤0.01% 2039
2021
Q4 		$1.6M Hold
37,600
– – ﹤0.01% 2202
2021
Q3 		$1.44M Hold
37,600
– – ﹤0.01% 2242
2021
Q2 		$1.06M Buy
+37,600
New +$1.13M ﹤0.01% 2455

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Swiss National Bank's HRMY Position: Q2 2026 in Review

Swiss National Bank increased its Harmony Biosciences (HRMY) stake by 12% in Q2 2026, buying an estimated $334K and bringing the position to 95,700 shares worth $3.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1646.

Swiss National Bank first reported a position in HRMY in Q2 2021 and has held it in 21 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Swiss National Bank held 95,700 shares of Harmony Biosciences worth $3.48M as of Q2 2026.
  • Swiss National Bank bought 10,600 Harmony Biosciences shares in Q2 2026, an estimated $334K.
  • Harmony Biosciences made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1646 holding.
  • Swiss National Bank first reported a position in Harmony Biosciences in Q2 2021 and has held it in 21 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.